Kansas City Cancer care, Southwest — Overland Park, Kansas

Kansas City Cancer care, Southwest is a clinical research site located in Overland Park, Kansas, United States 66210.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Kansas City Cancer care, Southwest has participated in 1 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City Cancer care, Southwest?

Kansas City Cancer care, Southwest has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City Cancer care, Southwest conducted?

Kansas City Cancer care, Southwest has 1 clinical trials on record. Their work covers Non-Small Cell Lung Cancer.

Is Kansas City Cancer care, Southwest accredited by Crixeo Health?

Kansas City Cancer care, Southwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kansas City Cancer care, Southwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.